Brazil
|
Fernandez-Becerra, 2010 [22]c
|
Rio Machado
|
DNS
|
PvMSP-1NT, PvMSP-119 (IgG)
|
CS (87)
|
Pv infection (LM or PCR), symptomatic Pv
|
Kano, 2012 [23]
|
Presidente Figueiredo, Amazonas
|
9 to 44
|
PvDBPII-IV, PvMSP-119 (IgG)
|
CS (432)
|
Pv infection (LM or PCR), symptomatic Pv
|
Lima-Junior, 2008 [24]d
|
Rondonia
|
10 to 85
|
PvMSP-9RIRII, PvMSP-9RII, PvMSP-9NT (IgG)
|
CS (282)
|
Pv infection
|
Lima-Junior, 2011 [25]
|
Rondonia
|
10 to 81
|
PvMSP-3αFL, PvMSP-3αNT, PvMSP-3αRI, PvMSP-3αRII, PvMSP-3αCT (IgG)
|
CS (282)
|
Pv infection
|
Lima-Junior, 2012 [26]
|
Rondonia
|
11 to 89
|
PvMSP-119 (IgG)
|
CS (277)
|
Pv infection
|
Nogueira, 2006 [27]
|
Portuchuelo, Rondonia
|
DNS
|
PvMSP-1NT, PvMSP-119 (IgG)
|
Cohort (173)
|
Pv infection
|
Oliveira-Ferreira, 2004 [28]
|
Candeias do Jamari, Rondonia
|
12 to 74
|
PvCSP (VK210, VK247, P. vivax-like) (IgG)
|
CS (61)
|
Pv infection
|
Souza-Silva, 2010 [29]
|
Acre
|
5 to 90
|
PvDBPII-IV (IgG)
|
Cohort (CS)e (366)
|
Pv infection, Pv infection (LM or PCR)
|
Tran, 2005 [30]f
|
Colina and Ribeirinha, Rondonia
|
11 to 75
|
PvRBP1 (IgG)
|
CS (87)
|
Pv infection
|
Versiani, 2013 [31]
|
Rio Pardo
|
DNS
|
PvMSP-1NT (IgG, IgG1, IgG2, IgG3, IgG4)
|
Cohort (CS)e (308)
|
Pv infection, symptomatic Pv
|
Indonesia
|
Ak, 1998 [32]
|
Robek
|
0 to 73
|
PvMSP-119 (IgG + IgM)
|
CS (169)
|
Pv infection
|
Woodberry, 2008 [33]
|
Timika, Papua
|
3 to 60
|
PvMSP-5 (IgG, IgM, IgG1, IgG2, IgG3, IgG4)
|
CC (340)
|
Symptomatic Pv
|
Papua New Guinea
|
Cole-Tobian, 2009 [34]
|
Madang
|
5 to 14
|
PvDBPII (AH, O, P, Sal 1), PvMSP-119 (IgG)
|
Cohortg (206)
|
Pv infection, Pv infection (LDR-FMA), Pv infection >150 parasites/μl
|
Fernandez-Becerra, 2010 [22]
|
Madang
|
0.25 to 3
|
PvMSP-1NT, PvMSP-119 (IgG)
|
CS (100)
|
Pv infection (LM or PCR), symptomatic Pv
|
King, 2008 [35]
|
Madang
|
5 to 14
|
PvDBPII binding inhibitory antibodies
|
Cohort (206)h
|
Pv infection
|
Stanisic, 2013 [36]
|
East Sepik
|
0.9 to 3.1
|
PvMSP-3αNT, PvMSP-3αRI, PvMSP-3αRII, PvMSP-3αCT, PvMSP-9NT, PvMSP-9RIRII (IgG)
|
Cohort (CS)e (183)
|
Pv infection (LDR-FMA), symptomatic Pv
|
Thailand
|
Fowkes, 2012 [37]
|
Mae Sot, Tak
|
15 to 42i
|
PvAMA1-ecto (IgG)
|
Nested CC (467)
|
Pv infection
|
Wongsrichanalai, 1991 [38]
|
Chanthaburi
|
DNS
|
PvCSP (VK210) (IgG)
|
CC (126)
|
Pv infection
|
Turkey
|
Yildiz Zeyrek, 2011 [39]
|
Sanliurfa
|
0 to 77
|
PvMSP-119, PvAMA1-ecto, PvSERA4, PvCSP (VK210 and VK247 chimera) (IgG, IgM, IgG1, IgG2, IgG3, IgG4)
|
CS (195)
|
Pv infection
|